Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study

OBJECTIVE: To compare some cycle characteristics and outcomes using a protocol consisting of a GnRH agonist trigger or hCG trigger after cotreatment with GnRH antagonist. STUDY DESIGN: Thirty-three patients under 35 years of age with polycystic ovarian syndrome, polycystic ovarian morphology, or p...

Full description

Saved in:
Bibliographic Details
Main Authors: Gulay Beydilli Nacak, Elif Tozkir, Enis Ozkaya, Ebru Cogendez, Fatih Kaya
Format: Article
Language:English
Published: Medical Network 2021-08-01
Series:Gynecology Obstetrics & Reproductive Medicine
Subjects:
Online Access:https://gorm.com.tr/index.php/GORM/article/view/1034
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823857340179283968
author Gulay Beydilli Nacak
Elif Tozkir
Enis Ozkaya
Ebru Cogendez
Fatih Kaya
author_facet Gulay Beydilli Nacak
Elif Tozkir
Enis Ozkaya
Ebru Cogendez
Fatih Kaya
author_sort Gulay Beydilli Nacak
collection DOAJ
description OBJECTIVE: To compare some cycle characteristics and outcomes using a protocol consisting of a GnRH agonist trigger or hCG trigger after cotreatment with GnRH antagonist. STUDY DESIGN: Thirty-three patients under 35 years of age with polycystic ovarian syndrome, polycystic ovarian morphology, or previous high response who underwent ovulation trigger by GnRH agonist trigger and 132 patients under 35 years of age with the polycystic ovarian syndrome, polycystic ovarian morphology, or previous high response who underwent ovulation trigger by hCG for IVF treatment. Patients were non-randomly assigned to an ovarian stimulation protocol consisting of either GnRH agonist trigger after cotreatment with GnRH antagonist (study group) or hCG trigger after antagonist protocol (control group). RESULTS: The positive pregnancy test was obtained in 70 women in the control group whereas in 13 cases in the study group (p=0.161). No case in the study group needed hospitalization whereas there were 15 cases in the control group who were required to be hospitalized due to ovarian hyperstimulation related symptoms (p=0.04). CONCLUSIONS: The use of a protocol consisting of a GnRH agonist trigger after GnRH antagonist cotreatment and freeze-all strategy reduces the risk of ovarian hyperstimulation syndrome in high-risk patients undergoing IVF without affecting pregnancy rates.
format Article
id doaj-art-402d2288505c4594bb8a86ca42d46e5a
institution Kabale University
issn 1300-4751
2602-4918
language English
publishDate 2021-08-01
publisher Medical Network
record_format Article
series Gynecology Obstetrics & Reproductive Medicine
spelling doaj-art-402d2288505c4594bb8a86ca42d46e5a2025-02-11T21:12:58ZengMedical NetworkGynecology Obstetrics & Reproductive Medicine1300-47512602-49182021-08-0127210.21613/GORM.2020.1034Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort StudyGulay Beydilli NacakElif Tozkir0Enis OzkayaEbru CogendezFatih KayaDepartment of Obstetrics and Gynecology OBJECTIVE: To compare some cycle characteristics and outcomes using a protocol consisting of a GnRH agonist trigger or hCG trigger after cotreatment with GnRH antagonist. STUDY DESIGN: Thirty-three patients under 35 years of age with polycystic ovarian syndrome, polycystic ovarian morphology, or previous high response who underwent ovulation trigger by GnRH agonist trigger and 132 patients under 35 years of age with the polycystic ovarian syndrome, polycystic ovarian morphology, or previous high response who underwent ovulation trigger by hCG for IVF treatment. Patients were non-randomly assigned to an ovarian stimulation protocol consisting of either GnRH agonist trigger after cotreatment with GnRH antagonist (study group) or hCG trigger after antagonist protocol (control group). RESULTS: The positive pregnancy test was obtained in 70 women in the control group whereas in 13 cases in the study group (p=0.161). No case in the study group needed hospitalization whereas there were 15 cases in the control group who were required to be hospitalized due to ovarian hyperstimulation related symptoms (p=0.04). CONCLUSIONS: The use of a protocol consisting of a GnRH agonist trigger after GnRH antagonist cotreatment and freeze-all strategy reduces the risk of ovarian hyperstimulation syndrome in high-risk patients undergoing IVF without affecting pregnancy rates. https://gorm.com.tr/index.php/GORM/article/view/1034GnRH agonistGnRH antagonistIVFOvarian hyperstimulation syndromePolycystic ovary morphologyPolycystic ovary syndrome
spellingShingle Gulay Beydilli Nacak
Elif Tozkir
Enis Ozkaya
Ebru Cogendez
Fatih Kaya
Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study
Gynecology Obstetrics & Reproductive Medicine
GnRH agonist
GnRH antagonist
IVF
Ovarian hyperstimulation syndrome
Polycystic ovary morphology
Polycystic ovary syndrome
title Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study
title_full Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study
title_fullStr Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study
title_full_unstemmed Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study
title_short Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study
title_sort comparison of hcg versus gonadotropin releasing hormone agonist to induce oocyte maturation in assisted reproductive technology cycles a retrospective cohort study
topic GnRH agonist
GnRH antagonist
IVF
Ovarian hyperstimulation syndrome
Polycystic ovary morphology
Polycystic ovary syndrome
url https://gorm.com.tr/index.php/GORM/article/view/1034
work_keys_str_mv AT gulaybeydillinacak comparisonofhcgversusgonadotropinreleasinghormoneagonisttoinduceoocytematurationinassistedreproductivetechnologycyclesaretrospectivecohortstudy
AT eliftozkir comparisonofhcgversusgonadotropinreleasinghormoneagonisttoinduceoocytematurationinassistedreproductivetechnologycyclesaretrospectivecohortstudy
AT enisozkaya comparisonofhcgversusgonadotropinreleasinghormoneagonisttoinduceoocytematurationinassistedreproductivetechnologycyclesaretrospectivecohortstudy
AT ebrucogendez comparisonofhcgversusgonadotropinreleasinghormoneagonisttoinduceoocytematurationinassistedreproductivetechnologycyclesaretrospectivecohortstudy
AT fatihkaya comparisonofhcgversusgonadotropinreleasinghormoneagonisttoinduceoocytematurationinassistedreproductivetechnologycyclesaretrospectivecohortstudy